3/15/2013 8:05:49 AM
Despite a tougher operating environment that including sagging U.S. sales of cholesterol medication Lipitor, Pfizer directors cite Read for company's strong performance. Pfizer CEO Ian Read's 2012 compensation rose slightly to $18 million in 2012, the pharmaceutical giant said Thursday. That's up from about $17.8 million in 2011. Read's 2012 pay package included $1.75 million in salary, $3.4 million in incentive pay and stock and stock options valued at $12.9 million and perks, including personal use of corporate aircraft, valued at nearly $175,000. Read also gained about $5.6 million from vested shares and exercising previously issued stock options, according to Pfizer's annual proxy filing. Read gained just $1.5 million from options and vested shares in 2011.
comments powered by